Pure Global
NCT06407141

The Effect of TPS on Cognitive Functions in Older Adults With MCI

The Effect of Transcranial Pulse Stimulation on Cognitive Functions in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial
The University of Hong Kong·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Drug/Device/Intervention
transcranial pulse stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The University of Hong Kong
Timeline & enrollment
Phase
N/A
Start date
May 08, 2024
End date
Aug 31, 2025
Enrollment
100 participants
Primary outcome

Improvement in Global Cognitive Function

Summary

The goal of this randomized controlled trial is to learn if Transcranial Pulse Stimulation
 (TPS) can improve cognitive functions in older adults with mild cognitive impairment (MCI).
 The study will also assess the safety of TPS. The main questions it aims to answer is:
 
 Does TPS improve cognitive functions such as global cognition, attention, memory, and
 executive function?
 
 Researchers will compare TPS to a sham control to evaluate the efficacy and safety of TPS in
 improving cognitive functions in older adults with MCI.
 
 Participants will:
 
 Be randomly assigned to receive either TPS or a sham intervention Undergo 6 sessions of TPS
 or sham intervention over a 2-week period Visit the clinic for cognitive assessments at 4
 different time points (baseline, immediately post-intervention, 1-month follow-up, and
 3-month follow-up) Complete questionnaires and undergo standardized neurocognitive tests,
 and/or MRI scans, and/or EEG assessments
 
 The study aims to provide insights into the potential therapeutic role of TPS in enhancing
 cognitive functions among older adults with mild cognitive impairment.

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06407141
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06407141 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Not yet recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.